ArticleInternational journal of molecular medicine2024

An LGR4 agonist activates the GSK‑3β pathway to inhibit RANK‑RANKL signaling during osteoclastogenesis in bone marrow‑derived macrophages.

Yuria Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.